Business The modern record industry is moving into its ‘cut to grow’ phase. – Music Business Worldwide Nick J Adam Nov 21, 2023 MBW Reacts is a series of analytical commentaries from Music Business Worldwide written in response to major recent… Read More...
Health Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO… James Pereira Jul 31, 2023 Phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Spero to receive $30 million… Read More...
Health Tonix Pharmaceuticals Announces Enrollment Initiated in the MGH Phase 2 ‘STROBE’ Study of TNX-1900… James Pereira Jul 31, 2023 Preliminary Data Show that Oxytocin Decreases Impulsivity and Reduces Food Intake TNX-1900 (Intranasal Potentiated… Read More...
Health IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of… James Pereira Jul 30, 2023 NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company… Read More...
Health 4DMT Presents Additional Positive Interim Data from Intravitreal 4D-150 Phase 1/2 PRISM Clinical… James Pereira Jul 29, 2023 Dose response demonstrated in favor of highest tested dose of 3E10 vg/eye, including 100% reduction in supplemental… Read More...
Health Annexon to Report ARCHER Phase 2 Trial Results in Geographic Atrophy at ASRS 2023 James Pereira Jul 24, 2023 BRISBANE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage… Read More...
Health Curium Announces Publication of [18F]DCFPyL Versus [18F]Fluoromethylcholine Results From European… James Pereira Jul 21, 2023 PARIS, July 21, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today the publication… Read More...
Business Prospera Energy Inc. Launches Game-Changing Phase 2 Development, On-Track to Boost Production and… Nick J Adam Jul 21, 2023 This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for… Read More...
Health ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA®… James Pereira Jul 21, 2023 LAUSANNE, Switzerland, July 20, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it… Read More...
Business MyRadar Awarded Phase I STTR contract By The Office of Naval Research (ONR) to Develop Advanced… Nick J Adam Jul 21, 2023 ORLANDO, Fla., July 20, 2023 (GLOBE NEWSWIRE) -- MyRadar, a leading provider of weather and environmental data… Read More...